Alzheimer’s Drug Development Company Cognition Therapeutics appoints Kenneth I. Moch President & CEO click here By John Harbison|2017-02-20T06:55:28-08:00October 28, 2016|Tech Coast Angels Portfolio Companies in the Press|Comments Off on Alzheimer’s Drug Development Company Cognition Therapeutics appoints Kenneth I. Moch President & CEO Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInWhatsAppTumblrPinterestVkXingEmail About the Author: John Harbison Related Posts
